Longitudinal Study of Ultra-rare Inherited Metabolic and Degenerative Neurological Diseases.

ConditionsInherited Disease Rare Diseases Metabolic Disease Undiagnosed Disease Neurologic Disorder Neuro-Degenerative Disease

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorFondazione I.R.C.C.S. Istituto Neurologico Carlo Besta

About this trial

General aim of the study is the improvement of the clinical knowledge of ultra-rare inherited metabolic and degenerative neurological diseases (prevalence less than 5:100,000) in adulthood through the systematic longitudinal collection of clinical, laboratory and instrumental data.

Eligibility criteria

Qualifiers

Age >= 18 years

Subjects with ultra-rare inherited degenerative and metabolic neurological diseases

Subjects with undiagnosed neurological diseases (when supposed to be inherited)

Disqualifiers

none

Trial design

Treatments tested in this trial

collection of data

Treatment groups

100 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta

Lead sponsor

Source ClinicalTrials.gov